UFM1通过激活Wnt/β-catenin信号通路增加三阴性乳腺癌细胞顺铂耐药

朱星瑀 ,  陈翔 ,  夏添松

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (6) : 496 -501.

PDF (839KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (6) : 496 -501. DOI: 10.12007/j.issn.0258‐4646.2026.06.003
论著

UFM1通过激活Wnt/β-catenin信号通路增加三阴性乳腺癌细胞顺铂耐药

作者信息 +

UFM1 enhances cisplatin resistance in triple-negative breast cancer cells via activation of the Wnt/β-catenin signaling pathway

Author information +
文章历史 +
PDF (858K)

摘要

目的 探究泛素折叠修饰因子1 (UFM1) 对三阴性乳腺癌 (TNBC) 细胞顺铂敏感性的影响及作用机制。方法 将TNBC细胞系MDA-MB-231分为ov-NC、ov-UFM1组、ov-UFM1+sh-NC组和ov-UFM1+sh-ESM1组; MDA-MB-231顺铂耐药 (MDA-MB-231/DDP) 细胞分为sh-NC组、sh-UFM1组、sh-UFM1+ov-NC组和sh-UFM1+ov-ESM1组。用CCK-8和流式细胞术检测各组细胞对放疗的敏感性; 实时定量PCR检测各组细胞中UFM1和内皮细胞特异性分子1 (ESM1) mRNA表达; Western blotting检测各组细胞中UFM1、ESM1和β-联蛋白 (β-catenin) 表达。结果 MDA-MB-231/DDP细胞中UFM1表达较MDA-MB-231细胞显著上调 (P < 0.05)。过表达UFM1升高顺铂处理的MDA-MB-231/DDP细胞的存活率,降低凋亡率,增加细胞中ESM1和β-catenin表达; 敲减UFM1则作用效果逆转。敲减ESM1降低顺铂处理的过表达UFM1的MDA-MB-231/DDP细胞的存活率并增加细胞的凋亡率,降低细胞中β-catenin表达。过表达ESM1增加顺铂处理的敲减UFM1的MDA-MB-231/DDP细胞的存活率并降低细胞的凋亡率,增加细胞中β-catenin表达。结论 UFM1通过上调ESM1表达降低TNBC细胞对顺铂的敏感性,其机制可能与诱导Wnt/β-catenin信号通路激活有关。

Abstract

Objective To analyze the effects and mechanisms of action of ubiquitin-fold modifier 1 (UFM1) on the sensitivity of triple-negative breast cancer (TNBC) cells to cisplatin. Methods MDA-MB-231 cells were divided into ov-NC,ov-UFM1,ov-UFM1+sh-NC,and ov-UFM1+sh-ESM1 groups. MDA-MB-231/DDP cells were divided into sh-NC,sh-UFM1,sh-UFM1+ov-NC,and sh-UFM1+ov-ESM1 groups. CCK-8 and flow cytometry were used to detect the sensitivity of cells to radiotherapy. Real-time quantitative PCR was used to detect the expression of UFM1 and endothelial cell-specific molecule 1 (ESM1) mRNA in the cells. Western blotting was used to detect the expression of UFM1,ESM1 and β-catenin. Results UFM1 mRNA expression was significantly upregulated in MDA-MB-231/DDP cells compared with that in MDA-MB-231 cells (P < 0.05). Overexpression of UFM1 increased the survival rate of MDA-MB-231/DDP cells treated with cisplatin,decreased the apoptosis rate,and increased the expression of ESM1 and β-catenin in the cells; in contrast,knockdown of UFM1 reversed the effects. Knockdown of ESM1 reduced the survival rate of cisplatin-treated MDA-MB-231/DDP cells with overexpressed UFM1,increased the apoptosis rate,and decreased the expression of β-catenin in the cells. Overexpression of ESM1 increased the survival rate of MDA-MB-231/DDP cells treated with cisplatin while knocking down UFM1,reduced the apoptosis rate of the cells,and increased the expression of β-catenin in the cells. Conclusion UFM1 reduced the sensitivity of TNBC cells to cisplatin by upregulating ESM1 expression,and its mechanism may be related to activation of the Wnt/β-catenin signaling pathway.

关键词

三阴性乳腺癌 / 泛素折叠修饰因子1 / 内皮细胞特异性分子1 / 顺铂耐药 / Wnt/β-catenin信号通路

Key words

triple-negative breast cancer / ubiquitin-fold modifier 1 / endothelial cell-specific molecule 1 / cisplatin resistance / Wnt/β-catenin signaling pathway

引用本文

引用格式 ▾
朱星瑀,陈翔,夏添松. UFM1通过激活Wnt/β-catenin信号通路增加三阴性乳腺癌细胞顺铂耐药[J]. 中国医科大学学报, 2026, 55(6): 496-501 DOI:10.12007/j.issn.0258‐4646.2026.06.003

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

VARZARU VB,VLAD T,POPESCU R,et al. Triple-negative breast cancer:molecular particularities still a challenge [J]. Diagnostics (Ba sel),2024,14 (17):1875. DOI:10.3390/diagnostics14171875.

[2]

PAJEWSKA M,PARTYKA O,CZERW A,et al. Advanced and meta-static triple negative breast cancer-potential new treatment [J]. Can cers,2025,17 (7):1183. DOI:10.3390/cancers17071183.

[3]

ZHU YX,HU YX,TANG CJ,et al. Platinum-based systematic thera-py in triple-negative breast cancer [J]. Biochim Biophys Acta Rev Cancer,2022,1877 (1):188678. DOI:10.1016/j.bbcan.2022.188678.

[4]

KOMATSU M,INADA T,NODA NN. The UFM1 system:working principles,cellular functions,and pathophysiology [J]. Mol Cell, 2024,84 (1):156-169. DOI:10.1016/j.molcel.2023.11.034.

[5]

张彦收,韩磊,刘学良,等. 基于生物信息学分析乳腺癌中UFC1表达及临床意义 [J]. 中国老年学杂志,2024,44 (13):3093-3097. 10.3969/j.issn.1005-9202.2024.13.006.

[6]

MAO MS,CHEN YX,YANG JJ,et al. Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impac- ting PD-L1 levels in triple-negative breast cancer [J]. J Immunother Cancer,2022,10 (12):e005668. DOI:10.1136/jitc-2022-005668.

[7]

ZHOU JZ,MA XH,HE XR,et al. Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target [J]. Proc Natl Acad Sci U S A,2023,120 (11):e2215732120. DOI:10.1073/pnas.2215732120.

[8]

ZHANG H,SHEN YW,ZHANG LJ,et al. Targeting endothelial cell-specific molecule 1 protein in cancer:a promising therapeu tic approach [J]. Front Oncol,2021,11:687120. DOI:10.3389/fonc.2021.687120.

[9]

LIU WT,YANG Y,HE BC,et al. ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway [J]. Ann Transl Med,2021,9 (7):533. DOI:10.21037/atm-20-7005.

[10]

FAN ZW,YE MZ,LIU D,et al. Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/ β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance [J]. Int Immunopharmacol,2024,137:112461. DOI:10.1016/j.intimp.2024.112461.

[11]

KE D,GUO HH,JIANG N,et al. Inhibition of UFM1 expression suppresses cancer progression and is linked to the dismal prognosis and immune infiltration in oral squamous cell carcinoma [J]. Aging, 2023,15 (22):13059-13076. DOI:10.18632/aging.205219.

[12]

LIN M,LIAN NZ,CAO LL,et al. Down-regulated expression of CDK5RAP3 and UFM1 suggests a poor prognosis in gastric can cer patients [J]. Front Oncol,2022,12:927751. DOI:10.3389/fonc.2022.927751.

[13]

HU ZH,WANG XH,LI D,et al. UFBP1,a key component in ufmy- lation,enhances drug sensitivity by promoting proteasomal degrada tion of oxidative stress-response transcription factor Nrf2 [J]. Onco gene,2021,40 (3):647-662. DOI:10.1038/s41388-020-01551-1.

[14]

ANTONY GR,LITTLEFLOWER AB,PARAMBIL ST,et al. PD-1/PD-L1 blockade inhibits epithelial-mesenchymal transition and im proves chemotherapeutic response in breast cancer [J]. Med Oncol,2023,40 (4):108. DOI:10.1007/s12032-023-01965-3.

[15]

GU X,ZHANG J,SHI YH,et al. ESM1/HIF-1α pathway modulates chronic intermittent hypoxia-induced non-small-cell lung cancer proliferation,stemness and epithelial-mesenchymal transition [J]. Oncol Rep,2021,45 (3):1226-1234. DOI:10.3892/or.2020.7913.

[16]

ZHAO MY,WANG T,HUI ZG. Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness [J]. Thorac Cancer,2020,11 (11):3117-3125. DOI:10.1111/1759-7714.13619.

[17]

PAN KF,LEE WJ,CHOU CC,et al. Direct interaction of β-cate-nin with nuclear ESM1 supports stemness of metastatic prostate cancer [J]. EMBO J,2021,40 (4):e105450. DOI:10.15252/embj.2020105450.

[18]

LIEB N,TRAN A,TORRES M,et al. Modulation of Wnt/beta-cate-nin pathway by major dietary phytochemicals against breast cancer development [J]. Biology,2025,14 (2):194. DOI:10.3390/biology14020194.

[19]

GARCÍA-AREAS R,GIRARD E,LASLA H,et al. Wnt signaling promotes inflammation and EMT-associated gene expression in mesenchymal TNBC [J]. Sci Rep,2026,4 (2):1-47. DOI:10.1038/s41598-026-43678-3.

基金资助

超声医学工程国家重点实验室项目(2021KFKT014)

AI Summary AI Mindmap
PDF (839KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉